Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan in Uterine Fibroids (ASTEROID 7)
NCT03699176Phase 3Withdrawn
- Sponsor
- Bayer
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of vilaprisan in Uterine Fibroids (UF), sponsored by Bayer. Planned start Oct 2018; status: withdrawn.
02
Drugs
vilaprisan
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT03699176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03699176.